February 3, 2015
Mireille Gillings, PhD, who with her husband Dennis Gillings, PhD, CBE, is a major benefactor of the Gillings School of Global Public Health, has been appointed to the U.S. corporate board of directors of the Pasteur Foundation. The Foundation, U.S. affiliate of the Paris-based Institut Pasteur, supports American scientific exchange through postdoctoral fellowships and other programs that advance scientific discovery.
Gillings is a veteran of the biotechnology industry and a published academic in the field of neuroscience. In 2004, she founded HUYA Bioscience International, a global leader in accelerating the co-development of biopharmaceutical product opportunities originating in China.
“Kudos and congratulations to Dr. Gillings on her appointment,” said Barbara K. Rimer, DrPH, dean and Alumni Distinguished Professor at the Gillings School. “Her scientific training and expertise, track record as a visionary entrepreneur and understanding of global health complement the focus of Institut Pasteur, through the Pasteur Foundation. As a global school, we are thrilled about the fellowships made possible by the generosity of Drs. Dennis and Mireille Gillings, and we look forward with enthusiasm to a long-term partnership with the Gillingses and Institut Pasteur.”
Gillings also serves on the board of Quintiles, a Fortune 500 company founded by Dennis Gillings; is a vice-chair and co-founder of GHO Capital, a private equity fund specialized in global health; and serves on the Senté board of directors.
She holds a doctorate from Radboud University Nijmegen (The Netherlands).
Gillings School of Global Public Health contact: David Pesci, director of communications, (919) 962-2600 or firstname.lastname@example.org.